Delivery Order SPE2DB22D1002-SPE2DB24FLHM1

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,603.00 Firm Fixed Price Delivery Order is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The award appears to be under a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,010.30, is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets in quantities of 100. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4,564,966,820 units of Hydromorphone Hydrochloride Extended Release 16 mg Tablets. The firm-fixed-price, delivery order contract is valued at $4,121.12 and has a completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of 12mg hydromorphone hydrochloride extended-release tablets to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The $10,039.59 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 12, 2025, with a completion date of May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 counts of 8 mg Hydromorphone Hydrochloride Extended Release tablets. The contract has a firm fixed price of $2,512.23 and a completion date of August 9, 2024. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a $2,425.97 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 8mg hydromorphone hydrochloride extended-release tablets, a pain management medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 12mg hydromorphone HCL extended-release tablets. The $4,275.66 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.24, is for the delivery of Hydromorphone HCL ER Tablets 12mg. This is a firm fixed-price delivery order contract with an ultimate completion date of January 22, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $2,184.76. The award is for the supply of 4,564,222,202 units of Hydromorphone HCL ER 8 mg tablets in 100-count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The contract is a delivery order with a firm fixed price of $5,274.41 and an ultimate completion date of October 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will be supplying this critical pain...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLHM1
    Delivery Order

This is a delivery order worth $1,481.33 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for hydromorphone hydrochloride extended-release 16 mg tablets, a critical pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This IDC enables the DLA to efficiently procure essential pharmaceutical and medical supplies from AmerisourceBergen.

The contract has a firm fixed-price pricing type and is not set aside for any specific business category. As a leading pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide array of prescription medications, medical supplies, and equipment to various government agencies and healthcare programs, including the military.

Generated 12/6/24, 9:29 AM